Compare Hims and Hers Health Inc (HIMS) vs Manchester United PLC (MANU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Manchester United PLC — how do they compare? Hims and Hers Health Inc trades at $32.75 (market cap $7.57B), while Manchester United PLC trades at $22.08 (market cap $3.80B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and Manchester United PLC pays a 1.26% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | MANU | |
|---|---|---|
Market Cap | $7.57B | $3.80B |
Sector | Health | Media |
52-Week High | $66.18 | $23.53 |
52-Week Low | $14.52 | $15.10 |
Enterprise Value | $7.95B | $4.72B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported 2025 revenue of $2.35 billion and net income of $128.37 million, though 2026 projections indicate a net loss. Recent news highlights executive departures and anticipation for Q2 2026 earnings on August 10, 2026.
The investment outlook is cautiously optimistic, supported by a 35% analyst buy rating and a $33.57 consensus price target. Key opportunities include growth in the weight-loss drug segment and international expansion. Risks involve profitability volatility, intense competition, and reliance on telehealth regulatory frameworks. The stock's valuation remains elevated with a P/E of 57.14, demanding strong future earnings growth to justify current levels.
Manchester United (MANU) trades at $22.45, up 0.99% on the day, with a neutral technical signal and mixed earnings performance. The company reported a net loss of $33.02M for 2025, though revenue grew to $666.51M. Recent news highlights progress on a new 100,000-seat stadium and Champions League qualification, which may boost future revenue. The stock's valuation shows a P/S of 4.21 and negative ROE of -6.36%, reflecting profitability challenges amid strategic investments.
The outlook is cautiously optimistic, driven by stadium development and sports performance, but high debt and inconsistent earnings pose risks. Analysts are mixed with 40% buy ratings. Investors should weigh growth initiatives against financial leverage and margin pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
